Cargando…
Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma
BACKGROUND: Renal cell carcinoma (RCC) is a cancer of increasing incidence and mortality. Currently, there are no immunohistochemical prognostic markers for RCCs in routine use. The aim of this study was to examine for the first time the immunostaining of myosin VI in RCCs as well as its association...
Autores principales: | Ronkainen, Hanna, Kauppila, Saila, Hirvikoski, Pasi, Vaarala, Markku H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837630/ https://www.ncbi.nlm.nih.gov/pubmed/20074327 http://dx.doi.org/10.1186/1756-9966-29-2 |
Ejemplares similares
-
Evaluation of neuroendocrine markers in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2010) -
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2011) -
Identification of androgen-regulated genes in human prostate
por: VAARALA, MARKKU H., et al.
Publicado: (2012) -
Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010
por: Laru, Lauri, et al.
Publicado: (2021) -
E-Cadherin Immunostaining in Equine Melanocytic Tumors
por: Pimenta, José, et al.
Publicado: (2023)